Search

everythinglearnresearchcommunity

for

Search:↓

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Certain alkaloids could help create new coronavirus drugs.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.

Combining standard treatment with exogenous cholinesterases can improve outcomes in severe organophosphate poisoning.

New compounds effective against SARS-CoV-2 variants were identified using a rapid testing method with human lung cells.

Blocking YAP/TAZ could be a new way to treat skin cancer.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

TLR7-based compounds may help manage chemotherapy-induced hair loss.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.